The Current Ratio as of December 2024 (TTM) for XOMA Corporation (XOMA) is 7.52

According to XOMA Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 7.52. This represents a change of -12.44% compared to the average of 8.59 of the last 4 quarters.

XOMA Corporation (XOMA) Historical Current Ratio (quarterly & annually)

How has XOMA Current Ratio performed in the past?

The mean historical Current Ratio of XOMA Corporation over the last ten years is 5.96. The current 7.52 Current Ratio has changed 12.52% with respect to the historical average. Over the past ten years (40 quarters), XOMA's Current Ratio was at its highest in in the September 2022 quarter at 14.70. The Current Ratio was at its lowest in in the December 2016 quarter at 0.84.

XOMA Corporation (XOMA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of XOMA Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

XOMA Corporation (XOMA) Average Current Ratio

How has XOMA Current Ratio performed in the past?

The current Current Ratio of XOMA Corporation (XOMA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

XOMA Corporation (XOMA) Current Ratio vs. Peers

How is XOMA’s Current Ratio compared to its peers?

XOMA Corporation’s Current Ratio is less than Werewolf Therapeutics, Inc. (10.10), less than Edgewise Therapeutics, Inc. (26.35), greater than Decibel Therapeutics, Inc. (4.81), less than Celcuity Inc. (10.36), greater than C4 Therapeutics, Inc. (6.31), less than Third Harmonic Bio, Inc. (42.50), greater than Passage Bio, Inc. (5.15), less than Acrivon Therapeutics, Inc. Common Stock (12.75), less than Eliem Therapeutics, Inc. (0), greater than TRACON Pharmaceuticals, Inc. (0.66), less than Rezolute, Inc. (13.79), greater than Sio Gene Therapies Inc. (5.52), greater than Vincerx Pharma, Inc. (2.17), greater than Stoke Therapeutics, Inc. (5.09), less than Crinetics Pharmaceuticals, Inc. (16.38), less than Dyne Therapeutics, Inc. (17.02), less than Revolution Medicines, Inc. (14.24), less than Design Therapeutics, Inc. (34.61), less than Tango Therapeutics, Inc. (8.00), less than Talaris Therapeutics, Inc. (40.33), greater than Achilles Therapeutics plc (6.04),

Build a custom stock screener for XOMA Corporation (XOMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

XOMA Corporation (XOMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like XOMA Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.